课题基金 / 基金详情

NON-A NON-B HEPATITIS

NON-A NON-B HEPATITIS
非甲非乙型肝炎
批准号:
3804830
负责人:
S M FEINSTONE
金额:
$0.0万
依托单位:
--
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

S M FEINSTONE的其他基金

相关文献

中文摘要
翻译
非甲非乙型肝炎(NANBH)自 霍顿成功克隆丙型肝炎病毒基因组, Chron等人的研究成果。我们开发了一种敏感的基于聚合酶链式反应的方法来检测 临床样本中的病毒基因组。这个化验结果看起来大约是10 比黑猩猩的感染性更敏感。我们已经证明了5‘ 丙型肝炎病毒RNA基因组的非编码区在 来自该地区的菌株和聚合酶链式反应引物似乎是通用的。我们 已经开发出一种新的诊断分析方法,它结合了一种基于酶的 微滴度聚合酶链式反应检测杂交法 临床标本中丙型肝炎病毒核糖核酸定量的简易方法我们发现了 复制形式的丙型肝炎病毒RNA不仅在感染患者的肝脏和 但令人惊讶的是,黑猩猩的血清中也有。进一步研究 澄清这一不同寻常的发现正在进行中。我们已经克隆了几乎 丙型肝炎病毒的整个基因组,并产生了大约9400个主克隆 长度包括整个编码区的核苷酸。编码 区域被插入到牛痘病毒载体中,希望 我们可以表达组装的丙型肝炎病毒颗粒,这将是一种有用的免疫原。 丙型肝炎病毒结构基因已插入杆状病毒表达 系统,并在诊断分析中用作抗原。研究:关于 丙型肝炎病毒的蛋白水解酶正在与查尔斯赖斯一起研究 病毒粒子多蛋白的加工及其结构与功能 酵素本身。我们正在合作开发组织培养系统 与哈里·格林伯格(斯坦福大学)和柯蒂斯·哈里斯(NCI)。 丙型肝炎病毒感染的免疫发病机制正在通过分离 T细胞表位。与J.Berzofsky合作,我们已经免疫 用表达丙型肝炎病毒NS5区的痘苗病毒感染小鼠,并检测 T细胞对来自同一区域的合成肽的反应。去约会一个人 可能的表位已被发现。我们还分离出了丙型肝炎病毒特异性杀手 来自感染黑猩猩肝脏浸润性淋巴细胞的T细胞系。
英文摘要
Progress in non-A, non-B hepatitis (NANBH) has been rapid since the successful cDNA cloning of the hepatitis C virus (HCV) genome by Houghton, et al.at Chiron. We have developed a sensitive PCR based method to detect the viral genome in clinical samples. This assay seems to be about 10 fold more sensitive than chimpanzee infectivity. We have shown that the 5' non-coding region of the HCV RNA genome is highly conserved between strains and PCR primers from this region that appear to be universal.We have developed a new diagnostic assay that combines an enzyme based detection hybridization assay with PCR in a microtiter format as a simplified method to quantitate HCV RNA in clinical samples. We have found replicate form of HCV RNA not only in the liver of infected patients and chimpanzees but also surprisingly in the serum as well. Further studies to clarify this unusual finding are in progress. We have cloned nearly the entire genome of HCV and produced a master clone of approximately 9400 nucleotides in length that includes the entire coding region. The coding region has been inserted into a vaccinia virus vector with the hopes that we can express assembled HCV particles that will be a useful immunogen.The Structural genes of HCV have been inserted into baculovirus expression systems and are being used as antigens in diagnostic assays. Studies on the protease of HCV are underway with Charles Rice in order to study the processing of the virion polyprotein and the structure and funtion of the enzyme itself. We are developing tissue culture systems in collaboration with Harry Greenberg (Stanford) and Curtis Harris (NCI). Immunopathogenesis of HCV infections is being investigated by isolating the T-cell epitopes.In collaboration with J.Berzofsky we have immunized mice with a vaccinia virus expressing the NS 5 region of HCV and test the T-cell response to synthetic peptides from the same region. To date one possible epitope has been found. We have also isolated HCV specific killer T-cell lines from liver infiltrating lymphocytes of infected chimpanzees.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HYBRIDOMA ANTIBODIES TO PATHOGENIC VIRUSES
HEPATITIS C VIRUS NEUTRALIZATION METHOD DEVELOPMENT
  • 批准号:
    6101194
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    S M FEINSTONE
  • 依托单位:
    --
STRUCTURAL AND ANTIGENIC ANALYSIS OF HEPATITIS A VIRUS
ANTIGENIC STRUCTURE OF HEPATITIS A VIRUS
  • 批准号:
    3811272
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    S M FEINSTONE
  • 依托单位:
    --